For research use only. Not for therapeutic Use.
JQAD1（Cat No.:I042318）is a small molecule compound under investigation for its potential as a therapeutic agent, particularly in cancer and autoimmune diseases. It works by targeting specific signaling pathways or enzymes involved in disease progression, such as those related to cell growth, survival, or immune system regulation. JQAD1 has shown promise in preclinical studies for its ability to modulate immune responses and inhibit tumor growth. Researchers are exploring its use in combination with other therapies to enhance efficacy. Further clinical trials are required to assess its safety, effectiveness, and therapeutic potential in treating various conditions.
| Catalog Number | I042318 |
| CAS Number | 2417097-18-6 |
| Synonyms | 12-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]amino]-N-[(5R)-3-[2-[(4-fluorophenyl)methyl-[(2S)-1,1,1-trifluoropropan-2-yl]amino]-2-oxoethyl]-2,4-dioxospiro[1,3-oxazolidine-5,1′-2,3-dihydroindene]-5′-yl]dodecanamide |
| Molecular Formula | C48H52F4N6O9 |
| Purity | ≥95% |
| IUPAC Name | 12-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]amino]-N-[(5R)-3-[2-[(4-fluorophenyl)methyl-[(2S)-1,1,1-trifluoropropan-2-yl]amino]-2-oxoethyl]-2,4-dioxospiro[1,3-oxazolidine-5,1'-2,3-dihydroindene]-5'-yl]dodecanamide |
| InChI | InChI=1S/C48H52F4N6O9/c1-29(48(50,51)52)56(27-30-12-14-32(49)15-13-30)41(61)28-57-45(65)47(67-46(57)66)23-22-31-25-34(17-19-37(31)47)54-39(59)11-9-7-5-3-2-4-6-8-10-24-53-33-16-18-35-36(26-33)44(64)58(43(35)63)38-20-21-40(60)55-42(38)62/h12-19,25-26,29,38,53H,2-11,20-24,27-28H2,1H3,(H,54,59)(H,55,60,62)/t29-,38?,47+/m0/s1 |
| InChIKey | TWCIGBYYSZQAAA-GWWVHQGYSA-N |
| SMILES | C[C@@H](C(F)(F)F)N(CC1=CC=C(C=C1)F)C(=O)CN2C(=O)[C@]3(CCC4=C3C=CC(=C4)NC(=O)CCCCCCCCCCCNC5=CC6=C(C=C5)C(=O)N(C6=O)C7CCC(=O)NC7=O)OC2=O |
